NCT03376308

Brief Summary

During general anesthesia, intravenous (IV) medications can disrupt the patient's comfort by causing a pain sensation or a withdrawal response in the heart. Propofol and rocuronium are among the most common causes of this condition. In recent years, the use of ultrasonography (USG) in anesthesia has become widespread with the rapid advancement of technology. The use of the patient's head is a non invasive method. This study is aimed to evaluate whether the size of the venous diameter assessed by ultrasonography in our study is an effect on pain and withdrawal response after drug injections.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 18, 2017

Completed
Last Updated

December 19, 2017

Status Verified

November 1, 2017

Enrollment Period

4 months

First QC Date

December 13, 2017

Last Update Submit

December 16, 2017

Conditions

Keywords

rocuroniumpropofolpainwithdrawalvenous diameter

Outcome Measures

Primary Outcomes (1)

  • The injection pain due to propofol

    Pain will be recorded and graded using a 4-point scale (none, mild, moderate, or severe).

    6 month

Secondary Outcomes (1)

  • The withdrawal movement due to rocuronium

    6 month

Study Arms (2)

Group 1

Venous diameter measurements were made via the USG in the hand dorsum. Transverse venous diameter ≤2mm was defined group 1. Anesthesia induction drugs were all treated in the same order and dose. Pain score, withdrawal movement score and hemodynamic response was recorded.

Diagnostic Test: Pain ScoreDiagnostic Test: Withdrawal movement scoreDiagnostic Test: hemodynamic response

Group 2

Venous diameter measurements were made via the USG in the hand dorsum.Transverse venous diameter \>2mm was defined group 2.Anesthesia induction drugs were all treated in the same order and dose. Pain score, withdrawal movement score and hemodynamic response was recorded.

Diagnostic Test: Pain ScoreDiagnostic Test: Withdrawal movement scoreDiagnostic Test: hemodynamic response

Interventions

Pain ScoreDIAGNOSTIC_TEST

Four poin scala 0=No Pain 1. mild 2. intermediate 3. severe

Group 1Group 2

Withdrawal movements 1. no movement response 2. movement limited to the wrist 3. movement limited to the elbow/shoulder, 4. generalized movement response.

Group 1Group 2
hemodynamic responseDIAGNOSTIC_TEST

Hemodynamic data were recorded in the patients taken in the operation room. (T0). Hemodynamic values (T1) measured 1 minute after administration of intravenous propofol were recorded. Hemodynamic values (T2) measured 1 minute after administration of intravenous rocuronium were recorded. Hemodynamic values (T3) measured 1 minute after administration of endotracheal intubation were recorded.

Group 1Group 2

Eligibility Criteria

Age17 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study was conducted on 145 patients aged 17- 70 years of ASA (American Society of Anesthesiologists) physical status I- II who were to undergo various elective operations. None of the patients was premedicated before the operation. Venous diameter measurements were performed in preoperative room via USG.The patients were monitored with three derivation electrocardiogram, non- invasive arterial pressure, and pulse oximeter.

You may qualify if:

  • years of ASA (American society of anesthesiology) physical status I- II who were to undergo various elective operations

You may not qualify if:

  • Rheumatologic disease Peripheric vascular disease Vasculitis Patients with chronic pain syndrome, Patients with neurologic deficits, Patients with thrombophlebitis, Patients with difficult venous access, Patients with allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adnan Menderes University Training and Research Hospital

Aydin, 09100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

Neurovascular Coupling

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cerebrovascular CirculationBlood CirculationCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Sinan Yılmaz

    Aydin Adnan Menderes University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 13, 2017

First Posted

December 18, 2017

Study Start

June 1, 2017

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

December 19, 2017

Record last verified: 2017-11

Locations